Archive

Report says that manufacturers must expand capabilities and capacity through strategic partnerships in order to fulfill demand

The US will show the highest growth in the MCD treatment market

What policy changes should be on the next Prime Minister's Agenda in order to re-vitalise the pharmaceutical industry in India?…

India’s pharmaceutical industry, which is estimated to be approximately $26 billion, has made us all proud. We are the world…

The Organisation of Pharmaceutical Producers of India (OPPI) represents the research-driven pharmaceutical companies in India and…

Affordability, availability and access to healthcare requires: Indian regulator to approve in a timely manner generics and…

It is said that the wealth of a nation depends on the health of its citizens. But ironically, the healthcare and pharmaceutical…

As India counts down to the start of the 2014 general elections, there is hope all around that these elections will usher in a…

Affordability, availability and access are becoming increasingly important particularly in the context of healthcare. The pharma…

Intellectual Property Rights (IPR) in India enjoy a very good status altough it has been criticised a lot by the US officials. The…